Karin Potthoff

8PUBLICATIONS
19CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 04, 2026
Real-World Evidence for Oncology Patients With Rare NTRK Gene Fusions: Final Results From the German Multicenter Patient Cohort Study REALTRK.

|Apr 02, 2026
Lenalidomide Plus Dexamethasone as FIRST-Line Therapy in Transplant-Ineligible Patients With Multiple Myeloma: Final Results of the Prospective, Non-Interventional Study FIRST-NIS and Comparison With the FIRST Pivotal Phase III Clinical Trial.

H Nückel, T Behlendorf, H Schulz

|Dec 10, 2024
Treatment adherence and effectiveness in patients treated with carfilzomib-based therapy combinations for relapsed/refractory multiple myeloma in Germany: interim results from the non-interventional CARO study.

Wolfgang Knauf, Jens Uhlig, Eyck von der Heyde

|Jun 13, 2023
The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice.

Uwe M Martens, Jan Schröder, Fee Bengsch

|Nov 22, 2021
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3).

Markus Moehler, Gunnar Folprecht, Volker Heinemann

|May 06, 2021
Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients.

Michael Metz, Dieter Semsek, Gunther Rogmans

Pageof 2

Frequent Collaborators

1 joint publications

Markus Moehler

1 joint publications

Gunnar Folprecht

1 joint publications

Volker Heinemann

1 joint publications

Julian Walter Holch